Risk of Regional Recurrence After Negative Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence

RT @AnnSurgOncol: MAY ISSUE: Risk of Regional Recurrence After Negative Repeat #SentinelLymphNodeBiopsy in Patients with Ipsilateral Breast…

RT @drzoewinters: #rSLNB #IBTR Perhaps a powered sample size based on likely event rate Difficult to perform RCT but #BigData valuable @AB…

RT @drzoewinters: #rSLNB #IBTR Perhaps a powered sample size based on likely event rate Difficult to perform RCT but #BigData valuable @AB…

#rSLNB #IBTR Perhaps a powered sample size based on likely event rate Difficult to perform RCT but #BigData valuable @ABSGBI https://t.co/PWsbS0CcZs

RT @AnnSurgOncol: MAY ISSUE: Risk of Regional Recurrence After Negative Repeat #SentinelLymphNodeBiopsy in Patients with Ipsilateral Breast…

RT @AnnSurgOncol: MAY ISSUE: Risk of Regional Recurrence After Negative Repeat #SentinelLymphNodeBiopsy in Patients with Ipsilateral Breast…

RT @AnnSurgOncol: MAY ISSUE: Risk of Regional Recurrence After Negative Repeat #SentinelLymphNodeBiopsy in Patients with Ipsilateral Breast…

RT @AnnSurgOncol: MAY ISSUE: Risk of Regional Recurrence After Negative Repeat #SentinelLymphNodeBiopsy in Patients with Ipsilateral Breast…

RT @AnnSurgOncol: MAY ISSUE: Risk of Regional Recurrence After Negative Repeat #SentinelLymphNodeBiopsy in Patients with Ipsilateral Breast…

MAY ISSUE: Risk of Regional Recurrence After Negative Repeat #SentinelLymphNodeBiopsy in Patients with Ipsilateral Breast Tumor Recurrence. https://t.co/baIHa07o4u